Minimal within-host dengue models highlight the specific roles of the immune response in primary and secondary dengue infections

In recent years, the within-host viral dynamics of dengue infections have been increasingly characterized, and the relationship between aspects of these dynamics and the manifestation of severe disease has been increasingly probed. Despite this progress, there are few mathematical models of within-host dengue dynamics, and the ones that exist focus primarily on the general role of immune cells in the clearance of infected cells, while neglecting other components of the immune response in limiting viraemia. Here, by considering a suite of mathematical within-host dengue models of increasing complexity, we aim to isolate the critical components of the innate and the adaptive immune response that suffice in the reproduction of several well-characterized features of primary and secondary dengue infections. By building up from a simple target cell limited model, we show that only the innate immune response is needed to recover the characteristic features of a primary symptomatic dengue infection, while a higher rate of viral infectivity (indicative of antibody-dependent enhancement) and infected cell clearance by T cells are further needed to recover the characteristic features of a secondary dengue infection. We show that these minimal models can reproduce the increased risk of disease associated with secondary heterologous infections that arises as a result of a cytokine storm, and, further, that they are consistent with virological indicators that predict the onset of severe disease, such as the magnitude of peak viraemia, time to peak viral load, and viral clearance rate. Finally, we show that the effectiveness of these virological indicators to predict the onset of severe disease depends on the contribution of T cells in fuelling the cytokine storm.

[1]  Alan S. Perelson,et al.  Modeling Within-Host Dynamics of Influenza Virus Infection Including Immune Responses , 2012, PLoS Comput. Biol..

[2]  Nuning Nuraini,et al.  A with-in host Dengue infection model with immune response , 2009, Math. Comput. Model..

[3]  Michael A. Johansson,et al.  The Incubation Periods of Dengue Viruses , 2012, PloS one.

[4]  Simon Wain-Hobson Virus Dynamics: Mathematical Principles of Immunology and Virology , 2001, Nature Medicine.

[5]  A. Rothman,et al.  Immunopathogenesis versus Protection in Dengue Virus Infections , 2014, Current Tropical Medicine Reports.

[6]  A. Mustafa,et al.  Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. , 2000, FEMS immunology and medical microbiology.

[7]  Anita Chakravarti,et al.  Circulating levels of tumour necrosis factor-alpha & interferon-gamma in patients with dengue & dengue haemorrhagic fever during an outbreak. , 2006, The Indian journal of medical research.

[8]  A. Dobson,et al.  Linking Influenza Virus Tissue Tropism to Population-Level Reproductive Fitness , 2012, PloS one.

[9]  A. Sabin Research on dengue during World War II. , 1952, The American journal of tropical medicine and hygiene.

[10]  A. Nisalak,et al.  Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. , 2002, The Journal of infectious diseases.

[11]  A. Rothman,et al.  Understanding the contribution of cellular immunity to dengue disease pathogenesis , 2008, Immunological reviews.

[12]  Alan S. Perelson,et al.  Mathematical Analysis of HIV-1 Dynamics in Vivo , 1999, SIAM Rev..

[13]  D. Hober,et al.  High Levels of sTNFR p75 and TNFα in Dengue‐Infected Patients , 1996 .

[14]  Pejman Rohani,et al.  Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity , 2013, Journal of The Royal Society Interface.

[15]  A. Rothman Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms , 2011, Nature Reviews Immunology.

[16]  A. Perelson Modelling viral and immune system dynamics , 2002, Nature Reviews Immunology.

[17]  J. Farrar,et al.  Timing of CD8+ T Cell Responses in Relation to Commencement of Capillary Leakage in Children with Dengue , 2010, The Journal of Immunology.

[18]  Andreas Handel,et al.  Towards a quantitative understanding of the within-host dynamics of influenza A infections , 2010, Journal of The Royal Society Interface.

[19]  Ravi V. Kolla,et al.  Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells , 2013, Proceedings of the National Academy of Sciences.

[20]  Matthew D. H. Lay,et al.  Killer T cells regulate antigen presentation for early expansion of memory, but not naive, CD8+ T cell , 2007, Proceedings of the National Academy of Sciences.

[21]  A. Basu,et al.  Vascular endothelium: the battlefield of dengue viruses , 2008, FEMS immunology and medical microbiology.

[22]  Sophie Yacoub,et al.  The pathogenesis of dengue , 2013, Current opinion in infectious diseases.

[23]  Tanvi P. Gujarati,et al.  Virus antibody dynamics in primary and secondary dengue infections , 2012, Journal of Mathematical Biology.

[24]  Ann Cullinane,et al.  Dynamics of Influenza Virus Infection and Pathology , 2010, Journal of Virology.

[25]  E. Harris,et al.  Innate immunity to dengue virus infection and subversion of antiviral responses. , 2014, Journal of molecular biology.

[26]  S. Halstead,et al.  Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection , 2013, Archives of Virology.

[27]  H. Ansari,et al.  A With-In Host Dengue Infection Model with Immune Response and Beddington-DeAngelis Incidence Rate , 2012 .

[28]  Yun-Chi Chen,et al.  Activation of Terminally Differentiated Human Monocytes/Macrophages by Dengue Virus: Productive Infection, Hierarchical Production of Innate Cytokines and Chemokines, and the Synergistic Effect of Lipopolysaccharide , 2002, Journal of Virology.

[29]  S. Sekaran,et al.  Cytokine Expression Profile of Dengue Patients at Different Phases of Illness , 2012, PloS one.

[30]  Laetitia Canini,et al.  Population Modeling of Influenza A/H1N1 Virus Kinetics and Symptom Dynamics , 2010, Journal of Virology.

[31]  Alan S. Perelson,et al.  Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy , 1998 .

[32]  Suresh Mahalingam,et al.  Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes , 2010, The Lancet Infectious Diseases.

[33]  M. Fernandez-Garcia,et al.  Pathogenesis of flavivirus infections: using and abusing the host cell. , 2009, Cell host & microbe.

[34]  D. Kirschner,et al.  A methodology for performing global uncertainty and sensitivity analysis in systems biology. , 2008, Journal of theoretical biology.

[35]  W. Yokoyama,et al.  The dynamic life of natural killer cells. , 2004, Annual review of immunology.

[36]  C. Thepparit,et al.  Behavior of the dengue virus in solution , 2003, Journal of medical virology.

[37]  A. Nisalak,et al.  Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. , 2000, The Journal of infectious diseases.

[38]  A. Nisalak,et al.  Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. , 1999, The Journal of infectious diseases.

[39]  Susana Vázquez,et al.  Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. , 2002, Revista panamericana de salud publica = Pan American journal of public health.

[40]  S. Yoksan,et al.  Alteration of Cytokines and Chemokines During Febrile Episodes Associated With Endothelial Cell Damage and Plasma Leakage in Dengue Hemorrhagic Fever , 2012, The Pediatric infectious disease journal.

[41]  Cameron P. Simmons,et al.  Kinetics of Viremia and NS1 Antigenemia Are Shaped by Immune Status and Virus Serotype in Adults with Dengue , 2011, PLoS neglected tropical diseases.

[42]  Gideon Schreiber,et al.  Prolonging the half-life of human interferon-α2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)7- interferon-α2 , 2001 .

[43]  A. Nisalak,et al.  Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. , 1991, The Journal of clinical investigation.

[44]  E. Harris,et al.  Early Clinical Features of Dengue Virus Infection in Nicaraguan Children: A Longitudinal Analysis , 2012, PLoS neglected tropical diseases.

[45]  S. Halstead,et al.  Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies. , 1990, The Journal of general virology.

[46]  Bjoern Peters,et al.  Immunodominance Changes as a Function of the Infecting Dengue Virus Serotype and Primary versus Secondary Infection , 2014, Journal of Virology.

[47]  Alan L Rothman,et al.  Dengue: defining protective versus pathologic immunity. , 2004, The Journal of clinical investigation.

[48]  C. King,et al.  Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  A. Nisalak,et al.  Cross-Reactivity and Expansion of Dengue-Specific T cells During Acute Primary and Secondary Infections in Humans , 2011, Scientific reports.

[50]  J. Farrar,et al.  Kinetics of Plasma Viremia and Soluble Nonstructural Protein 1 Concentrations in Dengue: Differential Effects According to Serotype and Immune Status , 2011, The Journal of infectious diseases.

[51]  A. Nisalak,et al.  Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. , 1989, The American journal of tropical medicine and hygiene.

[52]  D. Hober,et al.  High levels of sTNFR p75 and TNF alpha in dengue-infected patients. , 1996, Microbiology and immunology.

[53]  Xiaoping Tang,et al.  Both Viremia and Cytokine Levels Associate with the Lack of Severe Disease in Secondary Dengue 1 Infection among Adult Chinese Patients , 2010, PloS one.

[54]  S. Kapoor,et al.  Elevated levels of IL‐8 in dengue hemorrhagic fever , 1998, Journal of medical virology.

[55]  D. Hober,et al.  Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. , 1993, The American journal of tropical medicine and hygiene.

[56]  Marta Ospina,et al.  Serum levels of interleukin-6, tumor necrosis factor-alpha and interferon-gamma in infants with and without dengue. , 2008, Revista da Sociedade Brasileira de Medicina Tropical.

[57]  A. Perelson,et al.  Kinetics of Influenza A Virus Infection in Humans , 2006, Journal of Virology.

[58]  G. Schreiber,et al.  Prolonging the half-life of human interferon-alpha 2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)7- interferon-alpha 2. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[59]  Tao Dong,et al.  Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever , 2003, Nature Medicine.

[60]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[61]  E. Azeredo,et al.  NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease , 2006, Clinical and experimental immunology.

[62]  P. Desprès,et al.  Innate immune responses to dengue virus. , 2005, Archives of medical research.

[63]  E L Braga,et al.  Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever. , 2001, Memorias do Instituto Oswaldo Cruz.

[64]  Hana M. Dobrovolny,et al.  Assessing Mathematical Models of Influenza Infections Using Features of the Immune Response , 2013, PloS one.

[65]  Alan L Rothman,et al.  Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. , 2004, The Journal of infectious diseases.

[66]  Albert D. M. E. Osterhaus,et al.  Dengue Virus Pathogenesis: an Integrated View , 2009, Clinical Microbiology Reviews.

[67]  D. Tough,et al.  In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection , 2007, Immunology.

[68]  S. Green,et al.  Markers of dengue disease severity. , 2010, Current topics in microbiology and immunology.

[69]  J. Rajapakse,et al.  Serum Proteome and Cytokine Analysis in a Longitudinal Cohort of Adults with Primary Dengue Infection Reveals Predictive Markers of DHF , 2012, PLoS neglected tropical diseases.

[70]  D. Hober,et al.  Serum Levels of Tumor Necrosis Factor-α (TNF-α), Interleukin-6 (IL-6), and Interleukin-1β (IL-1β) in Dengue-Infected Patients , 1993 .

[71]  Hadi Dowlatabadi,et al.  Sensitivity and Uncertainty Analysis of Complex Models of Disease Transmission: an HIV Model, as an Example , 1994 .

[72]  Michael G. Katze,et al.  Into the Eye of the Cytokine Storm , 2012, Microbiology and Molecular Reviews.

[73]  Eduardo Hage Carmo,et al.  Influência do aumento do acesso à atenção básica no comportamento da taxa de detecção de hanseníase de 1980 a 2006 , 2008 .

[74]  Edward C. Holmes,et al.  Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes , 2013, Proceedings of the National Academy of Sciences.

[75]  S. Lada,et al.  Gamma Interferon (IFN-γ) Receptor Restricts Systemic Dengue Virus Replication and Prevents Paralysis in IFN-α/β Receptor-Deficient Mice , 2012, Journal of Virology.

[76]  N. Wauquier,et al.  Control of Acute Dengue Virus Infection by Natural Killer Cells , 2014, Front. Immunol..

[77]  Cameron P. Simmons,et al.  Within-host viral dynamics of dengue serotype 1 infection , 2014, Journal of The Royal Society Interface.

[78]  M. Guzmán,et al.  Tumor necrosis factor-alpha, transforming growth factor-β1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever. , 2010, Human immunology.

[79]  A S Perelson,et al.  Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. , 1998, Science.

[80]  B. Murphy,et al.  Immune response to dengue virus and prospects for a vaccine. , 2011, Annual review of immunology.

[81]  Eva Harris,et al.  Interferon-Dependent Immunity Is Essential for Resistance to Primary Dengue Virus Infection in Mice, Whereas T- and B-Cell-Dependent Immunity Are Less Critical , 2004, Journal of Virology.

[82]  M. Sinniah,et al.  Augmented inflammatory cytokines in primary dengue infection progressing to shock. , 1995, Singapore medical journal.